Ibrutinib Raises Sudden Cardiac Death Risk. 10/13/25

Welcome to Cardiology Today – Recorded October 13, 2025. This episode summarizes 5 key cardiology studies on topics like symptomatic atrial fibrillation and coronary sinus pacing. Key takeaway: Ibrutinib Raises Sudden Cardiac Death Risk.. Article Links: Article 1: Sudden Death and Asymptomatic Arrhythmia in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib. (Heart rhythm) Article 2: Insulin sensitivity, genetic predisposition, and risk of atrial fibrillation: a prospective cohort study. (Heart rhythm) Article 3: Alternative Pacing Strategies Following Transcatheter Tricuspid Valve Interventions: Procedural Challenges and Lessons Learned. (Heart rhythm) Article 4: Questioning the Role of Pulmonary Vein Isolation in Multimorbid Patients: A Prospective Analysis in Over 1,400 AF Patients. (Heart rhythm) Article 5: Asymptomatic Atrial Fibrillation: Clinical Characteristics, Outcomes, and Prognostic Impact of Rhythm Control. (Heart rhythm) Full episode page: https://podcast.explainheart.com/podcast/ibrutinib-raises-sudden-cardiac-death-risk-10-13-25/ Featured Articles Article 1: Sudden Death and Asymptomatic Arrhythmia in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077373 Summary: Article number one. Sudden Death and Asymptomatic Arrhythmia in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib. Article 2: Insulin sensitivity, genetic predisposition, and risk of atrial fibrillation: a prospective cohort study. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077371 Summary: Article number two. Insulin sensitivity, genetic predisposition, and risk of atrial fibrillation: a prospective cohort study. Article 3: Alternative Pacing Strategies Following Transcatheter Tricuspid Valve Interventions: Procedural Challenges and Lessons Learned. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077369 Summary: Article number three. Alternative Pacing Strategies Following Transcatheter Tricuspid Valve Interventions: Procedural Challenges and Lessons Learned. Article 4: Questioning the Role of Pulmonary Vein Isolation in Multimorbid Patients: A Prospective Analysis in Over 1,400 AF Patients. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077368 Summary: Article number four. Questioning the Role of Pulmonary Vein Isolation in Multimorbid Patients: A Prospective Analysis in Over 1,400 A.fib Patients. Article 5: Asymptomatic Atrial Fibrillation: Clinical Characteristics, Outcomes, and Prognostic Impact of Rhythm Control. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077365 Summary: Article number five. Asymptomatic Atrial Fibrillation: Clinical Characteristics, Outcomes, and Prognostic Impact of Rhythm Control. Transcript Today’s date is October 13, 2025. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Sudden Death and Asymptomatic Arrhythmia in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib. Article number two. Insulin sensitivity, genetic predisposition, and risk of atrial fibrillation: a prospective cohort study. Article number three. Alternative Pacing Strategies Following Transcatheter Tricuspid Valve Interventions: Procedural Challenges and Lessons Learned. Article number four. Questioning the Role of Pulmonary Vein Isolation in Multimorbid Patients: A Prospective Analysis in Over 1,400 A.fib Patients. Article number five. Asymptomatic Atrial Fibrillation: Clinical Characteristics, Outcomes, and Prognostic Impact of Rhythm Control. Thank you for listening. Don’t forget to subscribe. Keywords symptomatic atrial fibrillation, coronary sinus pacing, transcatheter tricuspid valve replacement, catheter ablation, rhythm control, clinical outcomes, Bruton’s tyrosine kinase inhibitor, transcatheter edge-to-edge repair, multimorbidity, European Heart Rhythm Association, prognosis, atrial fibrillation, arrhythmias, pulmonary vein isolation, China-A.F. registry, Ibrutinib, sudden cardiac death, cardiac pacing, U.K. Biobank, leadless pacemaker, estimated glucose disposal rate, prospective cohort study, genetic predisposition, early rhythm control, antiarrhythmic drugs, asymptomatic atrial fibrillation, transcatheter tricuspid valve intervention, chronic lymphocytic leukemia, insulin sensitivity. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Ibrutinib Raises Sudden Cardiac Death Risk. 10/13/25 first appeared on Cardiology Today.